Results
|
1.
|
Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial. MedStar authors:
Year: 2015
Citation: - Lancet Oncology. 16(9):1037-48, 2015 Sep.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Adams PT, Baez-Diaz L, Bear HD, Brufsky AM, Costantino JP, Fehrenbacher L, Gaur R, Geyer CE Jr, Gross HM, Liu Q, Mamounas EP, Margolese RG, Mehta RS, Paik S, Rastogi P, Robidoux A, Senecal FM, Swain SM, Tang G, Wolmark N, Young JA
|
|
2.
|
TARGIT-R (Retrospective): North American Experience with Intraoperative Radiation Using Low-Kilovoltage X-Rays for Breast Cancer. MedStar authors:
Year: 2016
Citation: - Annals of Surgical Oncology. 23(9):2809-15, 2016 Sep
Medline publication type:
- Journal Article
- Multicenter Study
All authors: - Abbott AM, Andolino DL, Bailey L, Bedi GC, Bethke KP, Boisvert ME, Bravo L, Cherian S, Collins BT, Deb N, Donnelly ED, Eaker JA, Escallon JM, Friedman NB, Fyles AW, Graves GM, Graves J, Greif JM, Grobmyer SR, Hermanto U, Hoefer RA, Joh JE, Kang SK, Kelemen P, Kelly T, Laronga C, Loftus L, Lottich SC, Lyons J, McCready DR, O'Rourke C, Pederson A, Police A, Riley L, Rohatgi N, Rosen B, Ross DL, Rudolph R, Ruffer J, Shaw CM, Small W Jr, Summer T, Tendulkar RD, Thompson WA 3rd, Tousimis EA, Uhl V, Valente SA, Willey SC, Wilson JP
|
|
3.
|
|
|
4.
|
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. MedStar authors:
Year: 2017
Citation: - Lancet Oncology. 18(11):1493-1501, 2017 Nov
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Attia S, Baker LH, Bolejack V, Burgess M, Butterfield LH, Crowley J, D'Angelo S, Davis LE, Hu J, Lazar AJ, Maki RG, Movva S, Okuno SH, Patel S, Priebat DA, Reed DR, Reinke D, Riedel RF, Rodriguez-Canales J, Salazar R, Schuetze SM, Tawbi HA, Van Tine BA, Wistuba II
|
|
5.
|
Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC. MedStar authors:
- Atkins, Michael
- Fishbein, Thomas M
- Satoskar, Rohit
Year: 2016
Citation: - Cancer Immunology Research. 4(5):419-30, 2016 May
Institution:
- MedStar Washington Hospital Center
- Washington Cancer Institute
Department:
- Georgetown Transplant Institute
- Surgery/Transplantation
Medline publication type:
All authors: - Atkins M, Banovac F, Feng P, Fishbein T, Gabrielson A, Gatalica Z, He AR, Island E, Jha R, Jiang J, Johnson L, Kachhela J, Kallakury B, Kleiner D, Loffredo C, Marshall J, Prins P, Reddy S, Satoskar R, Tesfaye A, Wang H, Weiner L, Wu Y, Zhang T
|
|
6.
|
Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24. MedStar authors:
Year: 2012
Citation: - Journal of Clinical Oncology. 30(12):1268-73, 2012 Apr 20.
Institution: - Washington Cancer Institute
Medline publication type:
- Comparative Study
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Allred DC, Anderson SJ, Costantino JP, Geyer CE Jr, Julian TB, Land SR, Mamounas EP, Nagtegaal ID, Paik S, Swain SM, Wickerham DL, Wolmark N
|